Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atrial-specific potassium channels are a group of cardiac ion channels that predominantly or exclusively contribute to the repolarization phase of the action potential in atrial cardiomyocytes, with minimal or no expression in ventricular tissue. These channels play a crucial role in shaping atrial action potentials and maintaining normal atrial rhythm, making them attractive targets for antiarrhythmic therapies—especially for conditions like atrial fibrillation (AF). Key subtypes include Kv1.5 (I_Kur), Kir3.x/GIRK (I_KACh), SK/KCNNs (I_SK), and TASK/KCNKs.
Inhibition of atrial-specific potassium channels to prolong atrial refractoriness and prevent arrhythmias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atrial-Specific Potassium Channel.